Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NXVNX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PNU-159682-P1C1TM
|
|||||
| Synonyms |
PNU-159682-P1C1TM
Click to Show/Hide
|
|||||
| Organization |
Sutro Biopharma;Yehui Pharma
|
|||||
| Drug Status |
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
~4.1
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Cellular tumor antigen p53 (TP53)
|
Antigen Info | ||||
| Payload Name |
PNU-159682
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||